title: Calcitonin gene-related peptide enhances substance P-induced behaviors via metabolic inhibition: in vivo evidence for a new mechanism of neuromodulation.
abstract: The present study examined the effects of intrathecal (i.t.) injection of calcitonin gene-related peptide (CGRP) on caudally directed biting and scratching induced by i.t. substance P (SP), bombesin (BBS), strychnine (STR), and kainic acid (KA). CGRP alone (5.25, 10.5 and 21 nmol) had no effect on these behaviors, but CGRP pretreatment produced a dose-related enhancement of behaviors induced by SP or BBS, but not by KA or STR. 2-Amino-5-phosphonovaleric acid (APV, 25 nmol), a selective N-methyl-D-aspartate (NMDA) receptor antagonist, did not block the CGRP potentiation of SP and BBS induced behaviors. CGRP, however, failed to enhance scratching and biting induced by a SP analogue [pGlu5-Mephe8-MeGly9]SP(5-11) (Dime-C7) that is resistant to enzymatic degradation by SP endopeptidase. These findings demonstrate that CGRP potentiates SP induced behavioral responses via inhibition of neuropeptide degradation and that this mechanism may serve as a physiological mechanism of SP modulation.
authors.affiliation: Department of Physiology, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298.
authors.forename: J
authors.initials: J
authors.lastname: Mao
authors.forename: R C
authors.initials: RC
authors.lastname: Coghill
authors.forename: D E
authors.initials: DE
authors.lastname: Kellstein
authors.forename: H
authors.initials: H
authors.lastname: Frenk
authors.forename: D J
authors.initials: DJ
authors.lastname: Mayer
mesh_terms: D015763:2-Amino-5-phosphonovalerate / Q000494:pharmacology; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001839:Bombesin / Q000494:pharmacology; D015740:Calcitonin Gene-Related Peptide / Q000494:pharmacology*; D002404:Catheterization; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D007278:Injections, Spinal; D007608:Kainic Acid / Q000494:pharmacology; D008297:Male; D008845:Microinjections; D010446:Peptide Fragments / Q000494:pharmacology; D011761:Pyrrolidonecarboxylic Acid / Q000031:analogs & derivatives; D051381:Rats; D011919:Rats, Inbred Strains; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors; D013331:Strychnine / Q000494:pharmacology; D013373:Substance P / Q000031:analogs & derivatives / Q000378:metabolism / Q000494:pharmacology*
chemical_list: D010446:Peptide Fragments; D016194:Receptors, N-Methyl-D-Aspartate; D013373:Substance P; D015763:2-Amino-5-phosphonovalerate; C032720:substance P (5-11), pGlu(5)-MePhe(8)-MeGly(9)-; D013331:Strychnine; D015740:Calcitonin Gene-Related Peptide; D001839:Bombesin; D007608:Kainic Acid; D011761:Pyrrolidonecarboxylic Acid